Blue Fin Capital, Inc. Drug Manufacturers

Blue Fin Capital, Inc.

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
LLY Eli Lilly & CO	$693B	$9.81 Million 1.9% of portfolio	11,071	Q3 2024 Added 2.04%
MRK Merck & Co., Inc.	$245B	$3.49 Million 0.68% of portfolio	30,750	Q3 2024 Reduced 0.17%
JNJ Johnson & Johnson	$400B	$3.1 Million 0.6% of portfolio	19,154	Q3 2024 Reduced 0.76%
ABBV Abb Vie Inc.	$295B	$2.91 Million 0.56% of portfolio	14,742	Q3 2024 Added 0.44%
AMGN Amgen Inc	$150B	$1.52 Million 0.29% of portfolio	4,711	Q3 2024 Reduced 2.34%
PFE Pfizer Inc	$141B	$721,000 0.14% of portfolio	24,923	Q3 2024 Reduced 7.88%
BMY Bristol Myers Squibb CO	$124B	$378,000 0.07% of portfolio	7,306	Q1 2024 Reduced 7.27%
NVS Novartis Ag	$222B	$255,000 0.05% of portfolio	2,220	Q3 2024 Reduced 4.68%

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Blue Fin Capital, Inc. with notifications on news.